Pfizer (PFE) announces that the US FDA has approved an expanded indication for HYMPAVZI® (marstacimab-hncq) to include the treatment of patients with hemophilia A or B 12 years and older

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Newsquawk Daily US Conference Calendar: PFE, REGN, BKNG, CRWD, MSFT, MU, NOW, SPGI. SNOW

Iran's National Security and Foreign Policy Commission of the Parliament says "after the ceasefire, the strengthening of the country's defense capabilities has continued without interruption... we are fully prepared to confront any new threat", SNN report

Pfizer (PFE) announces that the US FDA has approved an expanded indication for HYMPAVZI® (marstacimab-hncq) to include the treatment of patients with hemophilia A or B 12 years and older

Iran has activated air defences in Yazd and are confronting hostile targets, Al Jazeera reports

IAEA's Grossi says they have been denied access to the main Iranian nuclear facilities since June 2025

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free